Pharmacotherapy in Type 1 Diabetes
Authors:
- Angela McGibbonAMAngela McGibbon
- Cindy RichardsonCRCindy Richardson
- Cheri HernandezCHCheri Hernandez
- John DornanJDJohn Dornan
- 1 April 2013
- journal article
- research article
- Published by Elsevier in Canadian Journal of Diabetes
- Vol. 37, S56-S60
Abstract
No abstract availableThis publication has 83 references indexed in Scilit:
- Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysisActa Diabetologica, 2009
- Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH‐based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5‐nations trialDiabetic Medicine, 2005
- Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSIIDiabetes Care, 2005
- Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapyDiabetologia, 2004
- Continuous Subcutaneous Insulin Infusion Versus Multiple Daily InjectionsDiabetes Care, 2004
- Continuous subcutaneous insulin infusion with short‐acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost‐effectivenessDiabetes/Metabolism Research and Reviews, 2004
- A Randomized Trial of Continuous Subcutaneous Insulin Infusion and Intensive Injection Therapy in Type 1 Diabetes for Patients With Long-Standing Poor Glycemic ControlDiabetes Care, 2002
- Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trialsBMJ, 2002
- Comparison of Insulin Aspart With Buffered Regular Insulin and Insulin Lispro in Continuous Subcutaneous Insulin InfusionDiabetes Care, 2002
- Intensive Insulin Therapy With Insulin LisproDiabetes Care, 2001